This position involves working cross-functionally with Medical Affairs, Market Access, and Clinical Development to ensure alignment between evidence generation and strategic objectives. This role offers the opportunity to drive scientific leadership and innovation, developing new methodologies and evidence strategies to enhance the understanding of the value of oncology treatments and advance the organization’s mission of delivering life-changing therapies to patients worldwide. This position is remote.

Responsibilities:

• Execute integrated global HEOR strategies across pipeline and marketed oncology products, ensuring alignment with regulatory, market access, and reimbursement requirements across key geographies
• Contribute to and drive execution of end-to-end evidence generation plans across the product lifecycle, integrating clinical, economic, and real-world evidence to support value demonstration and access
• Execute and oversee the development of ex-US value Dossiers, ensuring alignment with clinical, economic, and epidemiologic evidence to support payer and HTA requirements
• Oversee the design and execution of real-world and observational studies (e.g., retrospective studies, prospective cohorts, registries) to generate evidence on effectiveness, safety, treatment patterns, and healthcare resource utilization
• Lead the development and adaptation of cost-effectiveness and budget impact models, ensuring alignment with global and local market access strategies and payer expectations
• Lead the design and execution of indirect treatment comparisons, external control arm studies and other comparative effectiveness approaches, ensuring methodological rigor and alignment with HTA expectations
• Oversee the development of systematic literature reviews and evidence syntheses to support HTA submissions, modeling inputs, and broader evidence strategies
• Provide strategic input into HTA submissions and payer engagement, ensuring that evidence packages address key uncertainties and support favorable reimbursement outcomes in global markets
• Drive innovation by advancing methodological approaches in health economics, epidemiology, and outcomes research, including novel frameworks to support value demonstration
• Identify and leverage appropriate real-world data sources (e.g., EHR, claims, registries) and establish external partnerships to support timely and high-quality evidence generation
• Develop and deliver clear, data-driven insights to internal leadership and external stakeholders, supporting alignment on the value proposition of oncology therapies
• Demonstrate strong leadership across cross-functional and cross-regional teams, fostering collaboration and driving high-quality, timely execution
• Uphold Corcept’s Key Principles by driving Collaboration, Embracing Possibility, Following the Data, and Leading by Doing, ensuring all initiatives align with the company’s ethics and patient-first mission

Preferred Skills, Qualifications and Technical Proficiencies:

• Proficiency in advanced statistical and modeling techniques for economic evaluation (e.g., Markov models, decision trees, cohort simulations)
• In-depth knowledge and ability to apply knowledge of US and global healthcare systems, global HTA requirements, and clinical development, to identify evidence gaps and formulate evidence generation and communication strategies
• Generate peer-reviewed publications to communicate study findings in scientific channels in alignment with the product publication strategy and the overall HEOR evidence generation strategy
• Expertise in the preparation and delivery of high-quality, evidence-based health economic reports and presentations to stakeholders at various levels (internal teams, HTA bodies, payers)
• Strong project management skills, with the ability to manage multiple priorities and deadlines
• Excellent communication and presentation skills

Preferred Education and Experience:

• Advanced degree (PhD, MSc, or equivalent) in health economics, public health, health policy, statistics, or a related field. A focus on oncology is highly desirable
• At least 10 years of experience in HEOR, with a strong background in oncology
• Demonstrated ability to lead cross-functional initiatives and influence senior stakeholders
• Proven experience in global HEOR strategy, HTA submissions, and payer engagement
• Strong expertise in health economic modeling, RWE, and comparative effectiveness research
• Demonstrated expertise in indirect treatment comparisons, real-world evidence generation, and observational study designs (e.g., registries)
• Strong understanding of US & EU healthcare systems, reimbursement pathways, and payer requirements
• Strong communication and presentation skills, with the ability to translate complex data into actionable insights
• 15% with travel as required

The pay range that the Company reasonably expects to pay for this remote position is $192,000 – $250,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

Applicants must be currently authorized to work in the United States on a full-time basis.